Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

Market Cap	7.02B
Revenue (ttm)	2.18B
Net Income (ttm)	529.31M
Shares Out	234.33M
EPS (ttm)	2.26
PE Ratio	13.26
Forward PE	12.75
Dividend	2.50 (8.32%)
Ex-Dividend Date	Jun 11, 2025

Volume	5,457,803
Average Volume	5,532,015
Open	29.55
Previous Close	29.97
Day's Range	29.55 - 30.45
52-Week Range	23.61 - 35.74
Beta	-0.08
RSI	47.67
Earnings Date	Jul 7, 2025

About Shandong Wit Dyne Health

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salt powder, montmorillonite powder, zithromycin granules, rifaximin dry suspension, and dithiothreitol succinate capsules. In addition, it offers infor...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 1,759
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000915

Financial Performance

In 2024, Shandong Wit Dyne Health's revenue was 2.13 billion, a decrease of -14.08% compared to the previous year's 2.48 billion. Earnings were 515.59 million, a decrease of -11.90%.